In Fundraising News, Press Releases

Julie Starns, Martin Kennedy and Linda Kennedy

The family of a Maidstone woman who died from a brain tumour have created an amazing legacy in her name.

Gill Kennedy died just 19 months after being diagnosed with a grade 4 glioblastoma in 2016 – the same type of tumour which the late Dame Tessa Jowell suffered from.

Her family have vowed to honour her memory and help other people in the same situation. They have established the Gill Kennedy Foundation, and already have raised more than £13,000.

The funds will be used by leading brain tumour support charity brainstrust to create and deliver 275 brain boxes – a unique set of resources, which are sent out from the charity to support
people living with a brain tumour.

Gill’s family said they had been overwhelmed by the support they received from two fundraising events they held in Maidstone.

Gill was diagnosed with a brain tumour after suffering a seizure on the way home from a holiday in Spain with her husband, Martin.

The family commented:

‘It came out of the blue, she had a seizure and the next thing we knew
she had been diagnosed with a glioblastoma. She was always so active, fit and healthy, it was
an incredible shock for us all. Gill always helped others, including volunteering for Sure Start
and the Alzheimer’s Society. She was a very popular and giving person; always putting others
first, so we felt it was important that we did something in her memory.’

The family received a brain box from brainstrust – which went on to inspire them to raise funds for other people to receive the valuable resource.

They added:

We had to go looking for information and support when mum was diagnosed and
only received the brain box two months before she died. We want to ensure that anyone else
in the same position is able to get support from the point of diagnosis. To be able to say that we
have created this legacy in Gill Kennedy’s name and can support over 250 people is fantastic.’

The family are well known in the Maidstone area, Julie owns and runs Sunrise Day Nursery and her brother Nick Kennedy and his wife Linda run the Kentish Lady boat cruises from the town.

Their donation has kick-started a fundraising campaign for the charity who are looking to fund an even greater number of brain boxes this year.

Will Jones, chief executive of brainstrust, said:

‘We are so grateful to Gill’s family for this incredible donation. A diagnosis of a brain tumour is both terrifying and bewildering, with people often uncertain of where to turn. Through our brain boxes we can help support people right when they need it most.’

‘This year we are expecting to send out around 1,000 brain boxes, more than double last year’s amount. This amazing amount of money, raised in memory of Gill, is a great start to this campaign and we are very grateful to her family for the donation.’

Around 10,000 people are diagnosed with a brain tumour every year. A glioblastoma is the most common and aggressive primary brain tumour.

For more information about the brainstrust campaign visit

sharon presenting trophyteam photo


The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here:


The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.


Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites


The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.


Not cancerousNon-malignant tumours may grow larger but do not spread to other parts of the body.


The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.


More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here: